India, June 1 -- Monday's top gainers include Turn Therapeutics following its interim analysis findings from an atopic dermatitis study; Conexeu Science on progress in its B.R.E.A.S.T. bioprinting program; LIXTE Biotechnology and its strategic transformation; and Quanterix amid insider transactions, among others.
Read on.
TTRX Turns Heads
Turn Therapeutics Inc. (TTRX) reported, on Monday, interim analysis findings and an adaptive optimization strategy from a phase 2 trial of GX-03 in moderate-to-severe atopic dermatitis, sending its stock up over 20%.
According to the company, 92.6% of GX-03-treated subjects achieved a 50% reduction in eczema severity in 4 weeks (EASI-50); 70.4% achieved a 75% reduction in 4 weeks (EASI-75); 44.4% achie...